Patent ID: 7939058

Claim:
A method for protecting or restoring hematopoiesis or enhancing peripheral blood cell counts in a mammal having at least one solid tumor, said method consisting essentially of: (a) administering a treatment to the mammal, wherein the treatment targets the solid tumor and has an associated hematopoietic toxicity; and (b) administering adjuvant therapy to alleviate the hematopoietic toxicity associated with said treatment, wherein the adjuvant therapy is selected from the group consisting of: (i) one therapeutically effective doses of IL-12 administered less than 36 hours before said treatment; (ii) one therapeutically effective dose of IL-12 administered at least 1 hour after said treatment; and (iii) one therapeutically effective dose of IL-12 administered less than 36 hours before said treatment and one therapeutically effective dose of IL-12 administered at least 1 hour after said treatment.